These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 15709032)
1. The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits viral replication through repression of Orf50/Rta transcriptional activation. DeWire SM; Damania B J Virol; 2005 Mar; 79(5):3127-38. PubMed ID: 15709032 [TBL] [Abstract][Full Text] [Related]
2. Kinetics of expression of rhesus monkey rhadinovirus (RRV) and identification and characterization of a polycistronic transcript encoding the RRV Orf50/Rta, RRV R8, and R8.1 genes. DeWire SM; McVoy MA; Damania B J Virol; 2002 Oct; 76(19):9819-31. PubMed ID: 12208960 [TBL] [Abstract][Full Text] [Related]
3. Murine Gammaherpesvirus 68 Expressing Kaposi Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen (LANA) Reveals both Functional Conservation and Divergence in LANA Homologs. Gupta A; Oldenburg DG; Salinas E; White DW; Forrest JC J Virol; 2017 Oct; 91(19):. PubMed ID: 28747501 [TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. Lan K; Kuppers DA; Verma SC; Robertson ES J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750 [TBL] [Abstract][Full Text] [Related]
5. A critical Sp1 element in the rhesus rhadinovirus (RRV) Rta promoter confers high-level activity that correlates with cellular permissivity for viral replication. DeMaster LK; Rose TM Virology; 2014 Jan; 448():196-209. PubMed ID: 24314650 [TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential. Wakeman BS; Izumiya Y; Speck SH J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414 [TBL] [Abstract][Full Text] [Related]
7. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus. Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396 [TBL] [Abstract][Full Text] [Related]
8. The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. Staudt MR; Dittmer DP Curr Top Microbiol Immunol; 2007; 312():71-100. PubMed ID: 17089794 [TBL] [Abstract][Full Text] [Related]
9. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50). Matsumura S; Fujita Y; Gomez E; Tanese N; Wilson AC J Virol; 2005 Jul; 79(13):8493-505. PubMed ID: 15956592 [TBL] [Abstract][Full Text] [Related]
10. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901 [TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway. Lan K; Kuppers DA; Robertson ES J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241 [TBL] [Abstract][Full Text] [Related]
13. Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus. Staudt MR; Dittmer DP Virology; 2006 Jun; 350(1):192-205. PubMed ID: 16616289 [TBL] [Abstract][Full Text] [Related]
14. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. Lu F; Day L; Gao SJ; Lieberman PM J Virol; 2006 Jun; 80(11):5273-82. PubMed ID: 16699007 [TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions. Cai Q; Lan K; Verma SC; Si H; Lin D; Robertson ES J Virol; 2006 Aug; 80(16):7965-75. PubMed ID: 16873253 [TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats. Verma SC; Lan K; Choudhuri T; Robertson ES J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612 [TBL] [Abstract][Full Text] [Related]
17. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. Xu Y; AuCoin DP; Huete AR; Cei SA; Hanson LJ; Pari GS J Virol; 2005 Mar; 79(6):3479-87. PubMed ID: 15731242 [TBL] [Abstract][Full Text] [Related]
18. Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus. Wen KW; Dittmer DP; Damania B J Virol; 2009 Oct; 83(19):9786-802. PubMed ID: 19587030 [TBL] [Abstract][Full Text] [Related]
19. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. Lu F; Zhou J; Wiedmer A; Madden K; Yuan Y; Lieberman PM J Virol; 2003 Nov; 77(21):11425-35. PubMed ID: 14557628 [TBL] [Abstract][Full Text] [Related]
20. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation. Carroll KD; Khadim F; Spadavecchia S; Palmeri D; Lukac DM J Virol; 2007 Aug; 81(16):8451-67. PubMed ID: 17537858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]